Gynecologic malignancies for which radical hysterectomy is indicated
Conditions
Interventions
None listed
Sponsors
Department of Anesthesiology, Nara Medical University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Scheduled radical hysterectomy undergoing M-TAPA in addition to general anesthesia at Nara Medical University Hospital.
Exclusion criteria
Exclusion criteria: Rejection Communication difficulty Chronic opioid use (Daily use or usage morphine equivalent more than 60mg per day within 1 month before surgery) Skin disease at puncture site History of previous surgery at abdomen Allergy to local anesthetics Coagulation disorder Patients who have received antithrombotic therapy and conflict with a sufficient period of drug withdrawal according to the guideline published by JSA/JSRA/JSPC Body weight < 45 kg BMI > 35 Visit restrictions due to prevention for COVID-19 Judged inappropriate by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of anesthetized dermatomal range by M-TAPA at 2 and 24 hours after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| Numerical rating scale (NRS) at 2/24/48 hours after surgery Opioid consumption after surgery Frequency of non-opioid analgesic use Occurrence of postoperative nausea and vomiting | — |
Countries
Japan
Contacts
Public ContactNobuhiro Tanaka
Nara Medical University Department of Anesthesiology
Outcome results
None listed